$18M sweet spot round size
Most of their 14 investments are in rounds between $7M and $60M
1996
Memo Therapeutics AG raised $25M on February 16, 2022
Investors: Zürcher Kantonalbank, Vesalius Biocapital, Adjuvant Capital and Fresenius Medical Care
SafeRide Health raised undisclosed on November 8, 2021
Investors: Primetime Partners, Sands Capital Management, Bonfire Ventures, SEMCAP and Fresenius Medical Care
Humacyte raised $175M on August 27, 2021
Investors: OrbiMed Advisors, Monashee Investment Management LLC and Fresenius Medical Care
eGenesis, Inc. raised $100M on November 7, 2019
Investors: 301 Ventures, Khosla Ventures, ARCH Venture Partners, Alta Partners, Biomatics Capital, Wellington Partners and Fresenius Medical Care
BioIntelliSense, Inc raised $25M on July 9, 2019
Investors: Fresenius Medical Care
SafeRide Health raised undisclosed on February 20, 2019
Investors: FCA Venture Partners, MBX Capital, Amplify.LA and Fresenius Medical Care
Modulim raised $7M on January 23, 2019
Investors: Pangaea Ventures, Grey Sky Venture Partners and Fresenius Medical Care
Tridiuum raised $9.5M on December 18, 2018
Investors: Sopris Capital and Fresenius Medical Care
Vectorious Medical Technologies raised $2M on July 16, 2018
Investors: Fresenius Medical Care
Humacyte raised $150M on June 11, 2018
Investors: Fresenius Medical Care